BlackRock Investment Management, LLC - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 31 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q1 2015$7,0000.0%15,247
+50.8%
0.00%–
Q4 2014$7,000
-22.2%
10,1100.0%0.00%–
Q3 2014$9,000
-10.0%
10,110
+11.8%
0.00%–
Q2 2014$10,000–9,041–0.00%–
 Download
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2015.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders